Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Cellular immune findings in Lyme disease.

Sigal LH, Moffat CM, Steere AC, Dwyer JM.

Yale J Biol Med. 1984 Jul-Aug;57(4):595-8.

2.

Cellular immune findings in Lyme disease. Correlation with serum IgM and disease activity.

Moffat CM, Sigal LH, Steere AC, Freeman DH, Dwyer JM.

Am J Med. 1984 Oct;77(4):625-32.

PMID:
6237576
3.

Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets.

Dattwyler RJ, Thomas JA, Benach JL, Golightly MG.

Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Dec;263(1-2):151-9.

PMID:
2953150
4.
5.

The antibody response in Lyme disease.

Craft JE, Grodzicki RL, Shrestha M, Fischer DK, García-Blanco M, Steere AC.

Yale J Biol Med. 1984 Jul-Aug;57(4):561-5.

6.

T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.

Krause A, Brade V, Schoerner C, Solbach W, Kalden JR, Burmester GR.

Arthritis Rheum. 1991 Apr;34(4):393-402.

PMID:
2012626
7.

Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.

Krause A, Rensing A, Kalden JR, Burmester GR.

Behring Inst Mitt. 1991 Feb;(88):52-8. Review. No abstract available.

PMID:
2049046
8.

Immunodiagnostic tests for Lyme disease.

Wilkinson HW.

Yale J Biol Med. 1984 Jul-Aug;57(4):567-72.

9.

Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.

Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, Steere AC.

Infect Immun. 2001 Dec;69(12):7437-44.

10.
11.

Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete.

Benach JL, Habicht GS, Gocinski BL, Coleman JL.

Yale J Biol Med. 1984 Jul-Aug;57(4):599-605.

12.
13.

Immunology of Lyme disease.

Sigal LH.

N J Med. 1990 Jul;87(7):567-71. Review.

PMID:
2200983
14.

Longitudinal investigation of bacterium-specific synovial lymphocyte proliferation in reactive arthritis and lyme arthritis.

Fendler C, Wu P, Eggens U, Laitko S, Sörensen H, Distler A, Braun J, Sieper J.

Br J Rheumatol. 1998 Jul;37(7):784-8.

PMID:
9714358
15.

Alterations in the T-lymphocyte subpopulation in patients with rhinoscleroma.

Berron P, Berron R, Ortiz-Ortiz L.

J Clin Microbiol. 1988 May;26(5):1031-3.

17.

Immunologic aspects of Lyme borreliosis.

Dattwyler RJ, Volkman DJ, Luft BJ.

Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1494-8. Review.

PMID:
2682961
18.

Immunochemical analysis of Lyme disease spirochetes.

Barbour AG.

Yale J Biol Med. 1984 Jul-Aug;57(4):581-6.

19.

Preferential usage of T cell antigen receptor V region gene segment V beta 5.1 by Borrelia burgdorferi antigen-reactive T cell clones isolated from a patient with Lyme disease.

Lahesmaa R, Shanafelt MC, Allsup A, Soderberg C, Anzola J, Freitas V, Turck C, Steinman L, Peltz G.

J Immunol. 1993 May 1;150(9):4125-35.

PMID:
7682589
20.

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease.

Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus SE, McFarland HF, Houghten R, Simon R, Pinilla C, Martin R.

Nat Med. 1999 Dec;5(12):1375-82.

PMID:
10581079

Supplemental Content

Support Center